Array of clinical trials in biosimilars

A clinical trial is an examination study that tests another restorative treatment or another method for utilizing a current treatment to check whether it will be a superior approach to counteract and screen for analyse or treat a disease1. For any new medication to enter in clinical trial, it must pass preclinical studies. Preclinical studies  of Biosimilars include in vitro (i.e. test-tube or Laboratory) studies and trials on creature populaces. Extensive variety of measurements of the study medication is given to creature subjects or to an in-vitro substrate with a specific end goal to acquire preparatory adequacy, poisonous quality and pharmacokinetic data and includes Preclinical Studies in Phase I-IV.

The proliferation of generic drugs  largely has been hailed as an economic and consumer triumph.  In 2013, more than 85% of all prescriptions in the United States were filled by generic drugs.  Under FDA regulations, generic drugs must be chemically equivalent, have the same active ingredients, and be bioequivalent to their branded counterparts.  However, the requirements for safety labelling on branded and generic drugs differ in important ways. Most notably, while a branded drug manufacturer is responsible for the accuracy and adequacy of its drug label, a generic drug company is responsible for ensuring that its warning label is the same as the label of the brand-name reference listed drug (RLD

  • Preclinical and Clinical Development
  • Optimising biosimilar clinical trial design
  • Biosimilars development and impact on clinical practice
  • Non-Clinical Studies in biosimilars development

Related Conference of Array of clinical trials in biosimilars

June 06-07, 2018

International Conference & B2B on Pharma Research and Development

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4thInternational Conference on Drug Discovery, Designing Chemistry and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Array of clinical trials in biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in